Xinghai Chen

Title: Innovations and Contributions of Inventor Xinghai Chen

Introduction

Xinghai Chen is a notable inventor based in Zhenjiang, China. He has made significant contributions to the field of pharmaceuticals, holding a total of 2 patents. His work focuses on developing compounds that exhibit beneficial pharmacological properties.

Latest Patents

Xinghai Chen's latest patents include a 1-[(pyridin-3-yl-sulfonyl)-1H-pyrrol-3-yl] methanamine derivative and a pharmaceutical composition that utilizes this compound. This derivative demonstrates good gastric acid secretion inhibitory activities and excellent pharmacodynamic properties, while maintaining relatively low toxicity. Another significant patent involves a deuterium substituted 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine compound. This compound is designed to reduce oxidative metabolism, increase drug concentration in blood, and enhance effective bioavailability, thereby lowering dosage and minimizing toxicity and side effects. It is particularly useful in treating affective disorders, depression, and anxiety.

Career Highlights

Throughout his career, Xinghai Chen has worked with prominent companies in the pharmaceutical industry, including Jiangsu Jibeier Pharmaceutical Co. Ltd. and Zhenjiang Sanan Pharmaceutical Co. Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Xinghai Chen has collaborated with notable colleagues such as Zhongyi Geng and Parker Aulma. These partnerships have likely facilitated the advancement of his research and the successful development of his patented compounds.

Conclusion

Xinghai Chen's contributions to pharmaceutical innovation are noteworthy, particularly through his patented compounds that address critical health issues. His work exemplifies the impact of dedicated inventors in advancing medical science and improving patient care.